[TOVX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
30-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 26.65%
YoY- 58.93%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -3,195 -2,537 -2,132 -2,111 -2,883 -2,990 -3,144 1.07%
Tax 0 -1 -23 -8 -16 -26 -4 -
NP -3,195 -2,536 -2,109 -2,103 -2,867 -2,964 -3,140 1.16%
Tax Rate - - - - - - - -
Total Cost 3,195 2,536 2,109 2,103 2,867 2,964 3,140 1.16%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.24 -0.28 -1.00 -1.08 -1.56 -1.73 -1.87 -74.58%
EPS Diluted -0.24 -0.28 -1.00 -1.08 -1.56 -1.73 -1.87 -74.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.